APA (7th ed.) Citation

MR, D., CP, G., Y, I., HG, W., TS, S., & VS, S. (2025). IGF2BP1 fosters an immunosuppressive tumor microenvironment in high-risk neuroblastoma, contributing to their resistance to immunotherapy. Oncoimmunology, 14(1), 2584408. https://doi.org/10.1080/2162402X.2025.2584408

Chicago Style (17th ed.) Citation

MR, Dhamdhere, Gowda CP, Imamura Y, Wang HG, Schell TS, and Spiegelman VS. "IGF2BP1 Fosters an Immunosuppressive Tumor Microenvironment in High-risk Neuroblastoma, Contributing to Their Resistance to Immunotherapy." Oncoimmunology 14, no. 1 (2025): 2584408. https://doi.org/10.1080/2162402X.2025.2584408.

MLA (9th ed.) Citation

MR, Dhamdhere, et al. "IGF2BP1 Fosters an Immunosuppressive Tumor Microenvironment in High-risk Neuroblastoma, Contributing to Their Resistance to Immunotherapy." Oncoimmunology, vol. 14, no. 1, 2025, p. 2584408, https://doi.org/10.1080/2162402X.2025.2584408.